CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-16 | Murdock Hunter R. General Counsel | Option exercise 10b5-1 | +7,500 | $29.91 | $224K | 7,500 |
| 2025-06-16 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −7,500 | $102.42 | $768K | 0 |
| 2025-06-16 | Murdock Hunter R. General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 44,883 | ||
| 2025-06-09 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +25,000 | $8.02 | $201K | 30,783 |
| 2025-06-09 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −25,000 | $110.44 | $2.8M | 5,783 |
| 2025-06-09 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 0 | ||
| 2025-06-06 | Coleman Mark Director | Grant or award · Stock Option (Right to Buy) | +3,166 | 3,166 | ||
| 2025-06-06 | Coleman Mark Director | Grant or award · Restricted Stock Units | +1,429 | 1,429 | ||
| 2025-06-06 | JEFFS ROGER Director | Grant or award · Stock Option (Right to Buy) | +3,166 | 3,166 | ||
| 2025-06-06 | JEFFS ROGER Director | Grant or award · Restricted Stock Units | +1,429 | 1,429 | ||
| 2025-06-06 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +3,166 | 3,166 | ||
| 2025-06-06 | Saad Mark E Director | Grant or award · Restricted Stock Units | +1,429 | 1,429 | ||
| 2025-06-06 | Mahony Susan Director | Grant or award · Stock Option (Right to Buy) | +3,166 | 3,166 | ||
| 2025-06-06 | Mahony Susan Director | Grant or award · Restricted Stock Units | +1,429 | 1,429 | ||
| 2025-05-28 | Coleman Mark Director | Sale 10b5-1 | −3,750 | $103.43 | $388K | 46,637 |
| 2025-05-28 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +20,000 | $6.47 | $129K | 25,783 |
| 2025-05-28 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −20,000 | $103.45 | $2.1M | 5,783 |
| 2025-05-28 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 0 | ||
| 2025-05-27 | Coleman Mark Director | Sale 10b5-1 | −3,750 | $105.47 | $396K | 50,387 |
| 2025-05-27 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +20,673 | $6.47 | $134K | 26,456 |
Page 9 of 22 · 422 trades